Federated Hermes’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-584
Closed -$16.9K 2117
2024
Q2
$16.9K Buy
584
+49
+9% +$2.33K ﹤0.01% 1730
2024
Q1
$23.9K Sell
535
-231
-30% -$9.89K ﹤0.01% 1707
2023
Q4
$29.7K Buy
766
+121
+19% +$4.36K ﹤0.01% 1708
2023
Q3
$19K Sell
645
-47
-7% -$2.23K ﹤0.01% 1769
2023
Q2
$44K Buy
+692
New +$38.3K ﹤0.01% 1691
2023
Q1
Sell
-25,660
Closed -$1.78M 2204
2022
Q4
$1.78M Hold
25,660
﹤0.01% 948
2022
Q3
$3.76M Hold
25,660
0.01% 736
2022
Q2
$3.35M Hold
25,660
0.01% 791
2022
Q1
$2.59M Buy
25,660
+15,385
+150% +$1.86M 0.01% 960
2021
Q4
$1.59M Sell
10,275
-15,675
-60% -$3.5M ﹤0.01% 1114
2021
Q3
$7.68M Sell
25,950
-3,462
-12% -$1.04M 0.01% 714
2021
Q2
$9.55M Buy
+29,412
New +$9.65M 0.02% 676

Other funds holding LYEL